Botulinum neurotoxin B engineered for increased receptor affinity has improved clinical potential. (December 2018) - Elliott, Mark; Favre-Guilmard, Christine; Liu, Sai Man; Maignel, Jacquie; Masuyer, Geoffrey; Beard, Matthew; Boone, Christopher; Carré, Denis; Kalinichev, Mikhail; Lezmi, Stephane; Mir, Imran; Nicoleau, Camille; et al.